A carregar...

Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia

BACKGROUND: Inhibitors of proprotein convertase subtilisin kexin 9 are indicated in Canada for treatment of patients with familial hypercholesterolemia (FH). Classically, FH is considered to be a monogenic condition caused by rare pathogenic mutations; however, some patients have hypercholesterolemi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CJC Open
Main Authors: Lee, Timothy, Iacocca, Michael A., Ban, Matthew R., Hegele, Robert A.
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7063626/
https://ncbi.nlm.nih.gov/pubmed/32159093
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cjco.2019.02.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!